Chemoinformaics analysis of 1,2- Benzenedicarboxylic acid
| Molecular Weight | 714.758 | nRot | 15 |
| Heavy Atom Molecular Weight | 664.358 | nRig | 2 |
| Exact Molecular Weight | 714.31 | nRing | 2 |
| Solubility: LogS | -1.49 | nHRing | 0 |
| Solubility: LogP | 1.216 | No. of Aliphatic Rings | 0 |
| Acid Count | 4 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 100 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 50 | No. of Aromatic Carbocycles | 2 |
| nHetero | 16 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 34 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 16 | No. of Arom Bond | 12 |
| nHA | 12 | APOL | 102.952 |
| nHD | 8 | BPOL | 58.8404 |
| QED | 0.57 |
| Synth | 1.641 |
| Natural Product Likeliness | 0.433 |
| NR-PPAR-gamma | 0.924 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.068 |
| CACO-2 | -5.745 |
| MDCK | 0.0000872 |
| BBB | 0.043 |
| PPB | 0.838855 |
| VDSS | 0.26 |
| FU | 0.152036 |
| CYP1A2-inh | 0.017 |
| CYP1A2-sub | 0.073 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.009 |
| CYP2c9-sub | 0.972 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.106 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.006 |
| CL | 1.727 |
| T12 | 0.85 |
| hERG | 0.005 |
| Ames | 0.008 |
| ROA | 0.008 |
| SkinSen | 0.13 |
| Carcinogencity | 0.137 |
| EI | 0.983 |
| Respiratory | 0.04 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.576808 |